VIA
USNA icon

Virtus Investment Advisers’s Usana Health Sciences USNA Stock Holding History

Virtus Investment Advisers’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,788
Closed -$212K – 374
2022
Q3 		$212K Buy
+3,788
New +$250K 0.1% 192

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtus Investment Advisers's USNA Position: Q4 2022 in Review

Virtus Investment Advisers sold out of Usana Health Sciences (USNA) in Q4 2022, closing a stake of 3,788 shares — an estimated $212K sold.

Virtus Investment Advisers first reported a position in USNA in Q3 2022 and held it in 1 quarter. The position peaked at $212K in Q3 2022. 167 funds tracked by Wall St. Rank hold USNA as of Q4 2022.

  • Virtus Investment Advisers reported no remaining Usana Health Sciences position as of Q4 2022 after selling out during the quarter.
  • Virtus Investment Advisers sold 3,788 Usana Health Sciences shares in Q4 2022, an estimated $212K.
  • Virtus Investment Advisers first reported a position in Usana Health Sciences in Q3 2022 and held it in 1 quarter.
  • Virtus Investment Advisers's Usana Health Sciences position peaked at $212K in Q3 2022.
  • 167 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2022.

Based on Virtus Investment Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.